QTRX
QTRX
NASDAQ · Life Sciences Tools & Services

Quanterix Corp

$3.28
-0.10 (-2.96%)
Financial Highlights (FY 2026)
Revenue
151.67M
Net Income
-117,009,632
Gross Margin
46.8%
Profit Margin
-77.1%
Rev Growth
+9.6%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 46.8% 46.8% 49.1% 49.1%
Operating Margin -90.4% -81.3% 5.5% 6.4%
Profit Margin -77.1% -73.3% 6.1% 4.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 151.67M 138.39M 208.12M 186.61M
Gross Profit 70.94M 64.72M 102.12M 91.57M
Operating Income -137,083,721 -112,568,748 11.39M 11.88M
Net Income -117,009,632 -96,084,551 12.69M 8.67M
Gross Margin 46.8% 46.8% 49.1% 49.1%
Operating Margin -90.4% -81.3% 5.5% 6.4%
Profit Margin -77.1% -73.3% 6.1% 4.6%
Rev Growth +9.6% +9.6% +19.2% -2.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 136.63M 133.70M
Total Equity — — 229.88M 201.96M
D/E Ratio — — 0.59 0.66
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -119,789,367 -103,832,024 15.93M 14.55M
Free Cash Flow — — 9.96M 8.22M